搜尋結果
宇学峰. 外文名. XUEFENGYU. 国 籍. 中国. 民 族. 汉族. 性 别. 男. 职 称. 南开大学药学院 教授. 目录. 1 人物经历. 2 职务任免. 3 获得荣誉. 4 研究方向. 5 主要贡献. 6 财富排名. 人物经历. 播报. 编辑. 宇学峰在 生物医药 领域深耕30多年。 在加入 康希诺 生物之前,宇学峰曾就职于 加拿大 IBEX Biotechnologies Inc. ,任产品研发科学家,从事药用 酶制剂 的研发;1998年加入全球五大疫苗企业之一 赛诺菲巴斯德 (Sanofi Pasteur Limited.),先后担任产品开发部科学家、 细菌疫苗 开发部加拿大分部总监及细菌疫苗开发全球总监。 [5-6] [9]
Xuefeng YU, co-founder, Chief Executive Officer(CEO) and Chairman of CanSino Biologics. He is primarily responsible for overseeing strategic development, overall operations and management as well as being the major decision-making force of our company.
Xuefeng Yu (喻学锋) Other names. Professor of Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences. Verified email at siat.ac.cn - Homepage. black phosphorus nanoscience and...
2021年4月6日 · Yu Xuefeng is co-founder, chairman and CEO of CanSino Biologics, a vaccine supplier. CanSino was founded in Tianjin in 2009. Yu received his doctorate degree in microbiology from McGill...
Dr. Xuefeng Yu is currently a Professor and Director of Materials and Interfaces Center at Institute of Advanced Materials Science and Engineering, Shenzhen Institutes of Advanced Technology,...
2022年5月21日 · CanSino Biologics CEO Yu Xuefeng. Photo: Getty Images. The World Health Organization approved the company’s viral vector vaccine for emergency use on Thursday, making it the third such Chinese...
Yu Xuefeng, CEO of Chinese vaccine maker CanSino Biologics, agreed that the technology had a way to go. He said it was a great addition to the pharmaceutical toolbox but not a “one solution for...